|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,528 GBX | +1.83% |
|
+1.56% | +5.40% |
| 05:11pm | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
| 10:20am | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
Jan 9 (Reuters) - British drugmaker GSK on Tuesday said it would acquire clinical-stage biopharmaceutical firm Aiolos Bio for a $1 billion upfront payment and up to $400 million in certain success-based regulatory milestone payments. (Reporting by Eva Mathews in Bengaluru; Editing by Rashmi Aich)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.40% | 79.3B | |
| +57.00% | 848B | |
| +31.64% | 627B | |
| -0.06% | 363B | |
| +15.39% | 318B | |
| +12.65% | 299B | |
| +15.51% | 243B | |
| +16.72% | 225B | |
| +16.22% | 179B | |
| +4.15% | 167B |
GSK PLC 
